Asia-Pacific Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Asia-Pacific Cancer Vaccines Market is Segmented on the basis of Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, and Other Technologies), Treatment Method (Preventive Vaccine and Therapeutic Vaccine), Application, and Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2021
CAGR: 12.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Certain factors that are driving the market's growth include the increasing burden of cancer cases and technological developments in cancer vaccines. The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. 

According to Glocbocan, in 2018, there were around 774,323 new cases of lung cancer, which contributed around 18% of total cancer cases in China. Cancer damages the immune system, as cancer cells produce self-antigen. The cancer vaccines play a vital role in the maintenance of the immune system, as they are considered to be biological response modifiers. These cancer vaccines target the infectious agents that may cause cancer, through the production of the antibodies. Cancer vaccines are considered to be a new therapy and are not popular, as compared to the other alternative therapeutic drugs. The cancer vaccines have shown great potential in both preventive and therapeutic ways. 

Hence, owing to the aforementioned factors, the market for cancer vaccines is expected to grow at a high rate, during the forecast period.

Scope of the report

As per the scope of the report, Cancer vaccines are defined as the vaccines developed to prevent or treat existing cancers, by strengthening the body’s natural immune response system against cancer. These cancer vaccines belong to a class of substances, known as biological response modifiers. These modifiers work by stimulating or restoring the immune system’s ability to fight against diseases.

By Technology
Recombinant Cancer Vaccines
Whole-cell Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Other Technologies
By Treatment Method
Preventive Vaccine
Therapeutic Vaccine
By Application
Prostate Cancer
Cervical Cancer
Other Applications
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Preventive Vaccines is Expected to Show Better Growth Over the Forecast Period.

Preventive vaccines or prophylactic vaccines are the vaccines intended to prevent cancer in healthy people. These vaccines work by preventing infectious agents that cause or contribute to the development of cancer. These vaccines are similar to traditional vaccines that help prevent infectious diseases, such as polio and measles, by protecting the body against infections. Most of the preventive vaccines stimulate the production of antibodies, which bind to specifically targeted microbes and block their ability to cause infection. Hence, owing to these factors, along with the rising burden of cancer, the market is expected to witness significant growth over the forecast period.

Asia-Pacific Cancer Vaccines Market 2.png

Competitive Landscape

The majority of cancer vaccines is being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. This has helped the market grow.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Cancer

      2. 4.2.2 Emphasis on Early Diagnosis of Cancer

      3. 4.2.3 Technological Developments in Cancer Vaccines

    3. 4.3 Market Restraints

      1. 4.3.1 Presence of Alternative Therapies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Technology

      1. 5.1.1 Recombinant Cancer Vaccines

      2. 5.1.2 Whole-cell Cancer Vaccines

      3. 5.1.3 Viral Vector and DNA Cancer Vaccines

      4. 5.1.4 Other Technologies

    2. 5.2 By Treatment Method

      1. 5.2.1 Preventive Vaccine

      2. 5.2.2 Therapeutic Vaccine

    3. 5.3 By Application

      1. 5.3.1 Prostate Cancer

      2. 5.3.2 Cervical Cancer

      3. 5.3.3 Other Applications

    4. 5.4 Geography

      1. 5.4.1 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific


    1. 6.1 Company Profiles

      1. 6.1.1 Astellas Pharma Inc.

      2. 6.1.2 AstraZeneca Plc

      3. 6.1.3 Glaxosmithkline Plc

      4. 6.1.4 Merck & Co., Inc.

      5. 6.1.5 Pfizer Inc.

      6. 6.1.6 Sanofi

      7. 6.1.7 Bristol-Myers Squibb

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Cancer Vaccines Market market is studied from 2018 - 2026.

The Asia-Pacific Cancer Vaccines Market is growing at a CAGR of 12.5% over the next 5 years.

AstraZeneca Plc, Glaxosmithkline Plc, Merck & Co., Inc., Pfizer Inc., Sanofi are the major companies operating in Asia-Pacific Cancer Vaccines Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!